Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Colin Forde has been awarded a National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA) Postdoctoral Award to lead a national study evaluating rehabilitation for people with a kneecap (patellar) dislocation.

The NIHR HTA Postdoctoral Career Development Award will support the PRePPeD (Physiotherapy Rehabilitation Post Patellar Dislocation) trial, which will compare two different approaches to rehabilitation following a kneecap dislocation. The study aims to provide the first high-quality evidence on the clinical and cost-effectiveness of different physiotherapy pathways for this common injury. 

An estimated 28,000 first-time kneecap dislocations occur in the UK each year. The kneecap dislocates when it slips out of the groove at the end of the thigh bone causing knee pain, swelling, and stiffness. Recovery can take months. Although patients are routinely referred for physiotherapy, there is currently little evidence to guide how much rehabilitation is needed in terms of volume and intensity. Increasingly, lower intensity models of rehabilitation that support patients to self-manage their injury are being used in the UK NHS. The PRePPeD trial will compare a single physiotherapy appointment that sets patients up to manage their own recovery with a course of multiple physiotherapy appointments of tailored advice and exercise to see which helps patient recover better and is better value for money. 

404 participants with a recent kneecap dislocation from at least 22 NHS hospitals will be recruited across the UK to see which method helps patients recover better and which is better value for money.

Colin Forde said: 'I am absolutely delighted to receive a NIHR HTA postdoctoral award. This award will allow me to lead my first national trial, which will find out what rehabilitation should be provided for people with a recent kneecap dislocation who are treated in the NHS.

'The award will also give me access to tailored training, mentorship and support that will help me design and lead other trials of injury rehabilitation in future.'

Patient and public involvement (PPI) was integral to the study and a group of 6 people with a previous kneecap dislocation of different ages, genders, and ethnicities helped in its design. 

The study's results will guide what physiotherapy is provided to patients with this injury who are treated in the NHS. 

Similar stories

Could patients with common fractures recover without routine hospital follow-up?

The FASTER study will investigate whether thousands of people with common fractures can recover just as well with good-quality advice and rehabilitation guidance, without the need for routine hospital follow-up appointments.

Could the gut’s nervous system hold new clues to treating Crohn’s disease?

Researchers at the Kennedy Institute are investigating whether the nervous system within the gut could provide a new way to understand and ultimately treat Crohn’s disease.

NDORMS appoints a new Research Professor of Regulatory Innovation to help accelerate the development pipeline of new treatments

Lincoln Tsang has been appointed as the new John Climax Research Professor of Regulatory Innovation – a new role at NDORMS and the University of Oxford that brings global regulatory and legal expertise to our ambitions to transform and improve drug development pathways in order to help deliver safe and effective treatments to patients sooner. He will assume this role effective 2 January 2027.

Look Beyond My Skin: Your Psoriasis Could Help Us Understand Who Develops Psoriatic Arthritis

Adults with psoriasis across Europe are invited to take part in an online study aiming to identify who is at risk of developing psoriatic arthritis.

New PI Marie Pust aims to bring microbiome research closer to patients

We welcome Marie-Madlen Pust, who has joined the Kennedy Institute as a new Principal Investigator. Marie will establish a research group combining computational biology with targeted experimental microbiology to identify microbial drivers of chronic inflammatory disease that can be monitored (diagnostic potential) or modified (therapeutic potential).

Oxford EMCRF starts pioneering engineered nTreg trial for severe autoimmune disease

The Oxford Experimental Medicine Clinical Research Facility (EMCRF) has recruited its first patients into the CHILL trial, an early-phase study of an innovative cell therapy for severe autoimmune disease.